VANGUARD GROUP INC - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 25 filers reported holding INHIBIKASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$348,709
+31.5%
530,2760.0%0.00%
Q4 2022$265,138
-45.0%
530,276
+0.0%
0.00%
Q3 2022$482,000
+22.3%
530,0980.0%0.00%
Q2 2022$394,000
-49.8%
530,0980.0%0.00%
Q1 2022$785,000
+11.5%
530,098
+10.7%
0.00%
Q4 2021$704,000
-22.6%
478,7040.0%0.00%
Q3 2021$909,000
-31.0%
478,704
+1.7%
0.00%
Q2 2021$1,318,000470,6150.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$696,0000.97%
HAMILTON LANE ADVISORS LLC 165,635$123,0000.05%
Redmond Asset Management, LLC 122,682$91,0000.03%
Retirement Planning Co of New England, Inc. 64,606$47,0000.03%
Antara Capital LP 403,000$299,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$70,0000.01%
Koshinski Asset Management, Inc. 65,377$49,0000.01%
K.J. Harrison & Partners Inc 18,300$14,0000.00%
Warberg Asset Management LLC 14,493$11,0000.00%
Shay Capital LLC 10,708$8,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders